Loss of TP53 mediates suppression of macrophage effector function via extracellular vesicles and PDL1 towards resistance against chemoimmunotherapy in B-cell malignancies
Journal article published in 2020 by
E. Izquierdo,
D. Vorholt,
J. L. Nolte,
B. Sackey,
Nolte Jl,
S. J. Blakemore,
J. Schmitz,
V. Barbarino,
O. Merkel,
N. Nickel,
R. Brinker,
D. Bachurski 
,
R. Neuhaus,
L. Lobastova,
M. Koch
and other authors.
,
R. Neuhaus,
L. Lobastova,
M. Koch
and other authors.
